BDX — BCAL Diagnostics Share News
0.000.00%
Last trade - 00:00- AU$27.65m
- AU$32.98m
- AU$2.55m
Brief: Bcal Diagnostics Posts HY Net Loss Attributable A$4 Mln
Brief: Bcal Diagnostics Announces Bcal Secures Commercial Licence Agreement With Sbc
Brief: BCAL Diagnostics Says Commenced U.S. Operations
Brief: Bcal Diagnostics Receives Firm Commitments To Raise A$10.5 Million
Australia's BCAL Diagnostics sees worst day in 10 months on discounted stock placement
Brief: Bcal Diagnostics Seeks Trading Halt
Brief: BCAL Diagnostics Says Shane Ryan Appointed CEO
Brief: Bcal Diagnostics Posts FY Net Loss Attributable A$5.1 Million
Brief: Bcal Diagnostics Annouces A$2.4M Capital Raise To Further Breastest Commercialisation
William Blair resumes Accelerate Diagnostics coverage with 'outperform'
Australia's BCAL Diagnostics rises on deal to develop tests for breast cancer
Brief: BCAL Diagnostics Says Entered An Agreement With Precion Inc
Australia Stock Exchange release from BCAL DIAGNOSTICS : Shareholder Newsletter
Australia Stock Exchange release from BCAL DIAGNOSTICS : Change of Director's Interest Notice
Australia Stock Exchange release from BCAL DIAGNOSTICS : PRE_NR Ends: 08:22:33
Australia Stock Exchange release from BCAL DIAGNOSTICS : Appendix 4D & Interim Report
Australia Stock Exchange release from BCAL DIAGNOSTICS : Shares to be released from escrow
Australia Stock Exchange release from BCAL DIAGNOSTICS : PRE_NR Ends: 14:51:48
Australia Stock Exchange release from BCAL DIAGNOSTICS : 7 February Announcement - Additional Information